Tumour necrosis factor α downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula [14]

Gut

Volumn 55, Issue 4, 2006, Pages 589-590

  Hassan, C ^a   Zullo, A ^a   Ierardi, E ^b   Burattini, O ^b   De Francesco, V ^b   Morini, S ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b Division of Gastroenterology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COLITIS; CROHN DISEASE; DOWN REGULATION; FOLLOW UP; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; COLITIS; COLITIS, ULCERATIVE; COLON; DIVERTICULUM, COLON; DOWN-REGULATION; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645122639     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.084756     Document Type: Letter

References (8)

1. Koulroubakis IE, Antoniou P, Tzardi M, et al. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis 2005;20:28-32.
2. Sandborn WJ, Faubion WA. Biologics in inflammatory bowel disease: how much progress have we made? Gut 2004;53:1366-73.
3. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005;128:1805-11.
4. Ierardi E, Monno R, Gentile A, et al. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol 2001;54:774-7.
5. Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-9.
6. Reinecker H-C, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1b by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
7. Baert FJ, D'Haens G, Peeters M, et al. Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999;116:22-8.
8. Imperiali G, Meucci G, Alvisi C, et al. Segmental colitis associated with diverticula: a prospective study. Am J Gastroenterol 2000;95:1014-16.